CureDM's Series C Round

CureDM raised a round of funding on August 17, 2009.

CureDM is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin.…

Articles about CureDM's Series C Round: